Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation - PubMed
- ️Thu Jan 01 2009
Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation
Shane P Herbert et al. Science. 2009.
Abstract
Blood vessels form de novo (vasculogenesis) or upon sprouting of capillaries from preexisting vessels (angiogenesis). With high-resolution imaging of zebrafish vascular development, we uncovered a third mode of blood vessel formation whereby the first embryonic artery and vein, two unconnected blood vessels, arise from a common precursor vessel. The first embryonic vein formed by selective sprouting of progenitor cells from the precursor vessel, followed by vessel segregation. These processes were regulated by the ligand EphrinB2 and its receptor EphB4, which are expressed in arterial-fated and venous-fated progenitors, respectively, and interact to orient the direction of progenitor migration. Thus, directional control of progenitor migration drives arterial-venous segregation and generation of separate parallel vessels from a single precursor vessel, a process essential for vascular development.
Figures

(A-E) Mid-trunk transverse sections (A, D), lateral views (B, E) or lateral time-lapse (C; movie S1) of Tg(kdrl:GFP)s843 (A-C) or Tg(kdrl:GFP)s843;Tg(gata1:dsRed)sd2 (D, E) embryos. Angioblasts coalesce and remodel to form the DA by 22hpf (white/red brackets; A-C). Between 21-24hpf, venous angioblasts sprout ventrally from the DA (arrowheads and dotted lines; A-C) and contribute to the CV primordium (yellow/blue brackets; A-C). ISVs sprout dorsally from 23hpf (arrows; B). By 25hpf, venous angioblasts surround Tg(gata1:dsRed)sd2-positive erythrocytes (asterisks, A, D; red cells, D, E). Erythrocyte displacement typically clears the CV lumen by 26hpf (A, D, E) but not in tnnt2 MO-injected embryos (E). Scale bars, 35 μm.

(A, B) Lateral views of Tg(kdrl:GFP)s843 embryos (A) or transverse sections of Tg(kdrl:GFP)s843;Tg(gata1:dsRed)sd2 embryos (B) injected with control, vegfa, plc1 or hey2 MO, or exposed to DMSO, SU5416, DAPT or LY294002. vegfa or plcγ1 MO-injection blocks ISV sprouting (asterisks), promotes excessive ventral sprouting (arrowheads), leads to loss of the DA (white bracket) and generates a single venous tube (yellow bracket). SU5416, DAPT, or hey2 MO-injection, also promote loss of the DA, whereas LY294002 blocks CV morphogenesis. Scale bars in, 35 μm.

(A-C) Tg(kdrl:GFP)s843 embryos were exposed to DMSO, LY294002 or AS605240, processed for microscopy (23hpf; A) and then scored for (B) the number of ventral sprouts (as a percentage of DMSO treated embryos) or (C) the percentage of cells in the DA (white bracket; a in graph) or CV (yellow bracket; v in graph). PI3K-inhibition blocks ISV sprouting (arrows), venous sprouting (asterisks) and angioblast ventral migration (arrowheads). Lateral images (D) and quantification (E) of donor-derived Tg(kdrl:GFP)s843 cells in wild-type hosts at 48hpf. Fewer cells from flt4 MO-injected donors contribute to the CV versus controls. Excessive ventral migration of angioblasts from plcγ1 MO-injected donors is reduced upon co-injection with flt4 MO. Scale bars, 35 μm. Error bars represent mean ± SEM. (*P < 0.05 versus control; **P < 0.05 versus plcγ1 MO; Student's t test).

(A, B) Lateral projections of Tg(kdrl:GFP)s843 embryos (A) or transverse sections of Tg(kdrl:GFP)s843;Tg(gata1:dsRed)sd2 embryos (B) injected with control, efnb2a, or ephb4a MO (A, B). Reduced Efnb2a expression promotes excessive ventral sprouting (A; arrowheads), loss of the DA (B; white bracket) and formation of a single vessel (A, B; yellow bracket) without affecting initiation of ISV sprouting (A; asterisks). Similarly, posterior arterial/venous segregation is disrupted in ephb4a MO-injected embryos. (C) Quantification of donor-derived Tg(kdrl:GFP)s843 cells in wild-type hosts at 30hpf. More cells from efnb2a MO-injected or ΔC-efnb2a over-expressing donors contribute to the CV versus controls, whereas less cells from ephb4a MO-injected donors contribute to the CV. Over-expression of efnb2a or ephb4a enhances the number of donor cells contributing to ISVs. Scale bars, 35 μm. Error bars represent mean ± SEM. (*P < 0.05; Student's t test).
Comment in
-
Development. Aorta's cardinal secret.
Benedito R, Adams RH. Benedito R, et al. Science. 2009 Oct 9;326(5950):242-3. doi: 10.1126/science.1181033. Science. 2009. PMID: 19815764 No abstract available.
Similar articles
-
Development. Aorta's cardinal secret.
Benedito R, Adams RH. Benedito R, et al. Science. 2009 Oct 9;326(5950):242-3. doi: 10.1126/science.1181033. Science. 2009. PMID: 19815764 No abstract available.
-
Arterial-venous specification during development.
Swift MR, Weinstein BM. Swift MR, et al. Circ Res. 2009 Mar 13;104(5):576-88. doi: 10.1161/CIRCRESAHA.108.188805. Circ Res. 2009. PMID: 19286613 Review.
-
Molecular identity of arteries, veins, and lymphatics.
Wolf K, Hu H, Isaji T, Dardik A. Wolf K, et al. J Vasc Surg. 2019 Jan;69(1):253-262. doi: 10.1016/j.jvs.2018.06.195. Epub 2018 Aug 25. J Vasc Surg. 2019. PMID: 30154011 Free PMC article. Review.
-
Convergence of Notch and beta-catenin signaling induces arterial fate in vascular progenitors.
Yamamizu K, Matsunaga T, Uosaki H, Fukushima H, Katayama S, Hiraoka-Kanie M, Mitani K, Yamashita JK. Yamamizu K, et al. J Cell Biol. 2010 Apr 19;189(2):325-38. doi: 10.1083/jcb.200904114. J Cell Biol. 2010. PMID: 20404113 Free PMC article.
-
Yang C, Guo Y, Jadlowiec CC, Li X, Lv W, Model LS, Collins MJ, Kondo Y, Muto A, Shu C, Dardik A. Yang C, et al. J Surg Res. 2013 Jul;183(1):478-86. doi: 10.1016/j.jss.2013.01.009. Epub 2013 Feb 1. J Surg Res. 2013. PMID: 23394931 Free PMC article.
Cited by
-
Rochon ER, Wright DS, Schubert MM, Roman BL. Rochon ER, et al. Cardiovasc Res. 2015 Jul 1;107(1):143-52. doi: 10.1093/cvr/cvv148. Epub 2015 May 12. Cardiovasc Res. 2015. PMID: 25969392 Free PMC article.
-
Campinho P, Lamperti P, Boselli F, Vermot J. Campinho P, et al. Philos Trans R Soc Lond B Biol Sci. 2018 Sep 24;373(1759):20170332. doi: 10.1098/rstb.2017.0332. Philos Trans R Soc Lond B Biol Sci. 2018. PMID: 30249780 Free PMC article.
-
Non-SH2/PDZ reverse signaling by ephrins.
Daar IO. Daar IO. Semin Cell Dev Biol. 2012 Feb;23(1):65-74. doi: 10.1016/j.semcdb.2011.10.012. Epub 2011 Oct 21. Semin Cell Dev Biol. 2012. PMID: 22040914 Free PMC article. Review.
-
Molecular mechanisms and clinical applications of angiogenesis.
Carmeliet P, Jain RK. Carmeliet P, et al. Nature. 2011 May 19;473(7347):298-307. doi: 10.1038/nature10144. Nature. 2011. PMID: 21593862 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous